Makers of generics should develop abuse-resistant oxycodone

04/22/2013 | New York Times (tiered subscription model), The

Makers of generic drugs should market their own abuse-resistant formulations of the painkiller OxyContin, or oxycodone, following an FDA ruling that will block the entry of generic versions of the original formulation from the market, according to this editorial.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI